Cerus Shares Spike To Afternoon High, Quickly Pare Gains And Then Some, Stock Now Near Session Lows Down 1.3%; Traders Recently Circulated Federal Procurement Data System Doc Showing Contract For Up to ~$201M For R&D In Biomedical, Biotech By Co.